GovChime
IDVOther than small business

IDC (multiple-award IDV) 75N91019D00021THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER

Overview

Award facts

Obligated on orders under this IDV
$13.78M
$13,778,484 across 13 orders
Period of performance
From Jan 25, 2019
Modifications
8
Latest action Jul 28, 2026
Contract type
IDC (multiple-award IDV)
PIID 75N91019D00021

Description of requirement

PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS (POP: 1/25/2019 - 1/24/2024)

Dates and value

Award date
Signed on Jan 24, 2019
Ordering period ends
Jan 24, 2024
Ceiling
Shared program ceiling (all awardees of this multiple-award vehicle, not a per-awardee value): $74,995,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 28, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationHOUSTON, TX
UEIS3GMKS8ELA16
CAGE code0KD38
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity

Business types and certifications

Educational institutionU.S. government entity

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Order dependent (IDV allows pricing arrangement to be determined separately for each order)1
Offers received
4

Solicitation and notices

Solicitation ID
N01CN7701918(as reported)

Contract details

Subcontracting plan
Individual subcontract planF
Major program
Prevent preclinical drug development program: preclinical efficacy&intermediate biomarkers
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jan 24, 2019
Latest action
Jul 28, 2026 — Supplemental agreement (within scope)Modification P00008
Latest substantive action
Jul 28, 2026 — Supplemental agreement (within scope)Modification P00008
Actions by type
  • Base award1
  • Supplemental agreement (within scope)4
  • Other administrative action3
  • New work added (outside scope)1
9 actions recorded, Jan 24, 2019 to Jul 28, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
Bio-basedE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
Yes

Place and origin

Domestic or foreign entity
Other U.S. entity (e.g. government)B

Structure

Award or IDV
IDV
IDV type
IDCB
Indefinite-delivery contract type
Indefinite delivery / indefinite quantityB
Multiple or single award
Multiple awardM
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
1

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910